Midostaurin is a protein kinase inhibitor used to treat acute myeloid leukemia and systemic mastocytosis. It works by blocking kinase enzymes in cancer cells, inhibiting their growth. Midostaurin is clinically significant for managing hematological malignancies. In summary, midostaurin is essential for treating blood cancers.
Midostaurin inhibits FLT3 and other kinases, disrupting signaling pathways essential for cancer cell proliferation.
No published brands for this salt yet.